Bain Capital Life Sciences Investors, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.11B
Q ending 2026-03-31
Prior quarter
$1.31B
Q ending 2025-12-31
Change
-15.1% QoQ · +64.0% YoY
Positions
20
reported holdings
Largest positions
All 20 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Heartflow Inc | HTFL | Shares | $254.2M | 10.4M |
| Newamsterdam Pharma Company | Shares | $233.9M | 7.3M | |
| Olema Pharmaceuticals Inc | OLMA | Shares | $111.4M | 7.5M |
| Savara Inc | SVRA | Shares | $96.1M | 17.6M |
| Pharvaris N V | Shares | $75.6M | 2.7M | |
| Solid Biosciences Inc | SLDB | Shares | $70.6M | 9.8M |
| X4 Pharmaceuticals Inc | XFOR | Shares | $32.9M | 8.0M |
| Dianthus Therapeutics Inc | DNTH | Shares | $30.4M | 362K |
| Annexon Inc | ANNX | Shares | $28.9M | 5.2M |
| Kyverna Therapeutics Inc | KYTX | Shares | $26.8M | 3.1M |
| Cabaletta Bio Inc | CABA | Shares | $26.0M | 9.7M |
| Centessa Pharmaceuticals | 260 | Shares | $25.2M | 635K |
| Alkermes Plc | Shares | $21.6M | 610K | |
| Rapid Micro Biosystems Inc | RPID | Shares | $19.1M | 8.4M |
| C4 Therapeutics Inc | CCCC | Shares | $18.9M | 7.2M |
| Atea Pharmaceuticals Inc | AVIR | Shares | $12.7M | 2.4M |
| Disc Medicine Inc | IRON | Shares | $9.0M | 141K |
| Upstream Bio Inc | UPB | Shares | $7.8M | 867K |
| Xilio Therapeutics Inc | XLO | Shares | $5.6M | 664K |
| Newamsterdam Pharma Company | Shares | $2.0M | 100K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.